Sentences with phrase «other cancer sequencing»

Now comes a second part of the study, something that sets it apart from other cancer sequencing efforts.

Not exact matches

They argue that anyone whose genome is sequenced for any medical reason should automatically learn whether 57 of their genes put them at risk of certain cancers, potentially fatal heart conditions, and other serious health problems.

Trent and others says that the same mechanism might be at work in genes linked to other cancers, such as breast and prostate cancer, which have been found to contain similar «harmless» sequence variations.

As the cost of gene sequencing drops, DNA being sequenced for one purpose may yield many other secrets, such as the risk of certain cancers and Alzheimer's disease.

The decline in sequencing costs has enabled researchers to more aggressively pursue the regulatory mechanisms underlying human development and disease progression in cancer, neurodegenerative diseases, and other medical conditions.

Recently, San Diego, California - based Illumina, one of largest manufacturers of sequencing machines, teamed up with Dana - Farber, MSKCC, and two other major U.S. cancer centers to define the «cancer actionable genome» to help tailor cancer therapies.

Colin Collins and Alexander Wyatt, and other researchers from the Vancouver Prostate Centre at the Vancouver Coastal Health Research Institute, matched 25 patients» treatment outcomes with the RNA sequence of their prostate cancer tumors.

Among these is BRG1 (also called SMARCA4) and the latest generation - sequencing technologies have extended these findings to other tumor types evidencing that BRG1 inactivation is widespread in cancer.

At the meeting, Tomas Walsh of the University of Washington, Seattle, reported on a test he and King developed, called BROCA, that sequences not only the BRCA genes, but also about 38 other cancer risk genes.

Alexis Borisy, CEO of Foundation Medicine, a cancer diagnostics company in Cambridge, Massachusetts, that studies how genetics can be translated into therapies, says that the study is «an excellent example of a coming wave of information from cancer genomes» that he expects to be sequenced in the future through the Cancer Genome Atlas and other procancer diagnostics company in Cambridge, Massachusetts, that studies how genetics can be translated into therapies, says that the study is «an excellent example of a coming wave of information from cancer genomes» that he expects to be sequenced in the future through the Cancer Genome Atlas and other procancer genomes» that he expects to be sequenced in the future through the Cancer Genome Atlas and other proCancer Genome Atlas and other projects.

In 2012, as part of efforts to better understand the causes of melanoma, researchers at the Broad Institute, the Dana - Farber Cancer Institute and a number of other institutes reported the results of whole genome sequencing of 25 human metastatic melanomas (Berger et al., 2012).

We are particularly interested in the identification of novel human proteins involved in inflammatory, immune and cancer processes that can not be characterized by sequence - based methods due to their low or not existing sequence similarity to others.

We published the first complete genome of a tumor in 2008 and have applied next - gen sequencing technologies to breast cancer, glioblastoma, ovarian cancer, leukemia, and other cancers.

The study is considered proof - of - principle that gene sequencing to identify cancer - related alterations may be a helpful tool in detecting cancer DNA directly in the blood and potentially other body fluids.

Since then, I've participated in the International HapMap Project, the Cancer Genome Atlas, the 1,000 Genomes Project, the Alzheimer's Disease Sequencing Project, and other large - scale collaborations.

The MyAML and MyHEME cancer panels are designed to analyze and interpret sequence information in genes known or suspected to be involved in AML and other hematologic diseases, respectively.

Fortunately, experiments done by Dr. Jan Vijg at the Albert Einstein College of Medicine and others on mutations (changes in base sequence in DNA) and additional studies commissioned by SENS Research Foundation on epimutations (changes in the arrangement of methyl groups) suggest that these latter kinds of alterations - the kind that accumulate in cells without triggering apoptosis or senescence or contributing to cancer - accumulate too slowly to make a difference with the current lifespan.

These initial findings have paved the way to expand the program into a more comprehensive pediatric precision oncology program that researchers expect to launch in 2016, which will include offering sequencing to pediatric cancer patients diagnosed at other hospitals.

Thanks in no small part to investments in researching cancer cells, gene sequencing, immunology and dozens of other fields, an American child born today can expect to live 30 years longer than one born in 1900.

However, being a complex multistep process, cancer cytogenetics are broadened to «cytogenomics,» with complementary resources on: general databases (nucleic acid and protein sequences databases; cartography browsers: GenBank, RefSeq, UCSC, Ensembl, UniProtKB, and Entrez Gene), cancer genomic portals associated with recent international integrated programs, such as TCGA or ICGC, other fusion genes databases, array CGH databases, copy number variation databases, and mutation databases.

Other uses of having a known link between multiple DNA sequencing reads includes studies of structural variations in for instance cancer cells, and when linking functional genes to taxonomic groups in microbial communities.

«Using the dog genome sequence in combination with the human genome sequence will help researchers to narrow their search for many more of the genetic contributors underlying cancer and other major diseases.»